Authors/Disclosures
		
			| Joshua M. Shulman, MD, PhD, FAAN
					(Duncan Neurological Research Institute) | Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation.  The institution of Dr. Shulman has received research support from National Institutes of Health. | 
		
			| Lori Chibnik | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| Robert G. Wilson, DO
					(cleveland clinic) | Dr. Wilson has nothing to disclose. | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| Matthew Huentelman
					(TGen) | Matthew Huentelman has nothing to disclose. | 
		
			|  | No disclosure on file | 
		
			| Eric M. Reiman, MD
					(Banner Alzheimer's Institute) | Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and  Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA. | 
		
			| David A. Bennett, MD
					(Rush University Medical Center) | Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. | 
		
			|  | No disclosure on file | 
		
			| Philip De Jager, MD, PhD
					(Columbia University Irving Medical Center) | Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen.  The institution of Dr. De Jager has received research support from roche.  The institution of Dr. De Jager has received research support from puretech. |